Author | Vasilios J. Assikis, MD

Articles

Risks and Benefits of Tamoxifen Therapy

February 01, 1997

Tamoxifen is the most widely prescribed endocrine therapy for breast cancer, with more than 7.5 million woman-years of clinical experience. Tamoxifen has both antiestrogenic and estrogenic activity. The antiestrogenic activity